There has been a series of confusing studies over estrogen. Many menopausal women went off the drug when increased rates of breast cancer were found. However, recent findings are challenging this conventional wisdom as a “major government study has found that years after using estrogen-only therapy, certain women had a markedly reduced risk of breast cancer and heart attack,” according to The New York Times. The key, says Tara Parker-Pope, reporter for The New York Times, is that these women were only on estrogen, and not progestin. She explains the findings and what this means for women.
The story you just read is available for free because thousands of listeners and readers like you generously support our nonprofit newsroom. Every day, reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you: We need your support to ensure we can continue this work for another year.
Make a gift today, and you’ll get us one step closer to our goal of raising $25,000 by June 14. We need your help now more than ever!